Alzheimer Dementia in People Living With HIV
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 24, 2020
- Accepted January 6, 2021
- First Published March 9, 2021.
Article Versions
- Previous version (March 9, 2021 - 14:25).
- You are viewing the most recent version of this article.
Author Disclosures
- Andrea Calcagno, MD,
- Luigi Celani, MD,
- Mattia Trunfio, MD,
- Giancarlo Orofino, MD,
- Daniele Imperiale, MD,
- Cristiana Atzori, BSc,
- Vincenzo Arena, MD,
- Gabriella d'Ettorre, MD, PhD,
- Giovanni Guaraldi, MD,
- Magnus Gisslen, MD, PhD and
- Giovanni Di Perri, MD, PhD
- Andrea Calcagno, MD,
(1) Viiv (2) MSD (3) Janssen-Cilag (4) Gilead
NONE
Commercial travel grants and speaker's honoraria from Gilead, Insmed, Janssen-Cilag, MSD, Viiv.
Since 2013 Associate Editor for BMC Infectious Diseases, since 2015 Vice Editor of Infectious Diseases and Tropical Medicine, since 2018 Academic Editor of PlosOne,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Research grants from Viiv and Gilead
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Luigi Celani, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mattia Trunfio, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Giancarlo Orofino, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Daniele Imperiale, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cristiana Atzori, BSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Vincenzo Arena, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gabriella d'Ettorre, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Giovanni Guaraldi, MD,
NONE
NONE
NONE
Journal of antimicrobial chemotherapy
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Magnus Gisslen, MD, PhD and
1.Gilead Sciences 2. BMS 3. Janssen 4. MSD
NONE
1. Gilead, speaker honoraria 2. BMS, speaker honriria 3. Janssen, speaker honoraria 4. Amgen, speaker honoraria 5. Biogen, speaker honoraria 6. Novocure, speaker honoraria 7. Novo Nordic, speaker honoraria
1. HIV&Virology News, Editor, 2016 2. AIDS Research and Therapy, editorial adv board, 2016
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1. Gilead 2. Janssen 3. GSK/ViiV
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Giovanni Di Perri, MD, PhD
Commercial for Janssen-Cilag, Viiv, MSD, BMS and Abbvie
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Commercial from Gilead
NONE
NONE
Research grants from Gilead, BMS, Abbvie, MSD and Viiv
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Unit of Infectious Diseases (C. Andrea, MT, GDP), Department of Medical Sciences, University of Torino, Italy; Department of Public Health and Infectious Diseases (LC, GE), Sapienza University of Rome, Italy; “Divisione A” Unit of Infectious Diseases (GO), Ospedale Amedeo di Savoia, ASL Città di Torino, Italy; Unit of Neurology (DI, C. Atzori), Ospedale Maria Vittoria, ASL Città di Torino, Italy; AFFIDEA Irmet PET/CT Center (VA), Torino, Italy; Department of Surgical (GG), Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy; Department of Infectious Diseases (MG), Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Sweden; and Region Västra Götaland (MG), Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg, Sweden.
- Correspondence
Dr. Calcagno andrea.calcagno{at}unito.it
Article usage
Cited By...
The Nerve!: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.